Through comprehensive functional genetic manipulation approaches in both in vitro (human GC cell lines) and in vivo (cell-derived tumor xenograft mouse models) systems, we systematically investigated the tumor-suppressive effects of FBXW2. This evidence concerns the gene FBXW2 and gastric cancer.